These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1592534)

  • 1. Pleiotropic actions of suramin on the proliferation of human breast-cancer cells in vitro.
    Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Dorssers LC; Berns EM; Klijn JG
    Int J Cancer; 1992 May; 51(3):439-44. PubMed ID: 1592534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of breast cancer growth by suramin.
    Vignon F; Prebois C; Rochefort H
    J Natl Cancer Inst; 1992 Jan; 84(1):38-42. PubMed ID: 1738172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of suramin on cell-cycle kinetics of MCF-7 human breast cancer cells in vitro.
    Foekens JA; Sieuwerts AM; Stuurman-Smeets EM; Peters HA; Klijn JG
    Br J Cancer; 1993 Feb; 67(2):232-6. PubMed ID: 8431356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of suramin on cell proliferation of various types of human malignant cells].
    Bai LY; Miyazaki M; Namba M
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):387-91. PubMed ID: 1848419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory effect of suramin on the proliferation of human glioma cells.
    Kuratsu J; Kurino M; Fukunaga K; Miyamoto E; Ushio Y
    Anticancer Res; 1995; 15(4):1263-8. PubMed ID: 7654006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin-induced growth inhibition and insulin-like growth factor-I binding blockade in human breast carcinoma cell lines: potentially related events.
    Ravera F; Miglietta L; Pirani P; Ferrini S; Favoni RE
    Eur J Cancer; 1993; 29A(2):225-30. PubMed ID: 8422287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proliferation of human cerebral meningioma cells by suramin: effects on cell growth, cell cycle phases, extracellular growth factors, and PDGF-BB autocrine growth loop.
    Schrell UM; Gauer S; Kiesewetter F; Bickel A; Hren J; Adams EF; Fahlbusch R
    J Neurosurg; 1995 Apr; 82(4):600-7. PubMed ID: 7897522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin inhibits the growth of non-small-cell lung cancer cells that express the epidermal growth factor receptor.
    Fujiuchi S; Ohsaki Y; Kikuchi K
    Oncology; 1997; 54(2):134-40. PubMed ID: 9075785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines.
    Favoni RE; Ravera F; Pirani P; Ardizzoni A; Noonan D; de Cupis A
    Eur J Pharmacol; 1994 Oct; 264(2):199-206. PubMed ID: 7851483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of schedule, protein binding and growth factors on the activity of suramin.
    Lopez Lopez R; Peters GJ; van Loenen AC; Pizao PE; van Rijswijk RE; Wagstaff J; Pinedo HM
    Int J Cancer; 1992 Jul; 51(6):921-6. PubMed ID: 1639540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
    Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
    J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of growth stimulation by suramin in non-small-cell lung cancer cell lines.
    Lokshin A; Peng X; Campbell PG; Barsouk A; Levitt ML
    Cancer Chemother Pharmacol; 1999; 43(4):341-7. PubMed ID: 10071987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
    Kalli KR; Bradley SV; Fuchshuber S; Conover CA
    Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of suramin on human lung cancer cell line in vitro].
    Fujiuchi S; Tsuji T; Ohsaki Y; Kikuchi K
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):647-52. PubMed ID: 8154891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Suramin activity in human head and neck squamous cell carcinoma cell lines].
    Li AT
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(2):108-9, 125. PubMed ID: 8217281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of basic fibroblast growth factor in suramin-induced inhibition of V79/AP4 fibroblast cell proliferation.
    Bernardini N; Giannessi F; Bianchi F; Dolfi A; Lupetti M; Citti L; Danesi R; Del Tacca M
    Br J Cancer; 1993 Jun; 67(6):1209-16. PubMed ID: 7685616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells.
    Kraft A; Reid LM; Zvibel I
    Cancer Res; 1993 Feb; 53(3):652-7. PubMed ID: 8381048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.
    Takano S; Gately S; Neville ME; Herblin WF; Gross JL; Engelhard H; Perricone M; Eidsvoog K; Brem S
    Cancer Res; 1994 May; 54(10):2654-60. PubMed ID: 7513254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.